Chemical formula: C₁₉H₁₇NO₇ Molecular mass: 371.341 g/mol PubChem compound: 50294
Nedocromil is indicated for:
Population group: only adults (18 - 65 years old)
Nedocromil is recommended for the treatment of bronchial asthma where regular preventative anti-inflammatory therapy is indicated and, in particular, in patients whose asthma is not adequately controlled by bronchodilators alone. Nedocromil may be given in addition to all existing therapies and in many cases will provide added therapeutic benefit.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Nedocromil is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
